Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04310176
Title Valproic Acid in Combination With Bevacizumab and Oxaliplatin/Fluoropyrimidine Regimens in Patients With Ras-mutated Metastatic Colorectal Cancer (REVOLUTION)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors National Cancer Institute, Naples

colorectal adenocarcinoma


Bevacizumab + Capecitabine + Oxaliplatin

Bevacizumab + Capecitabine

Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin

Bevacizumab + Fluorouracil

Bevacizumab + Fluorouracil + Valproic acid

Bevacizumab + Capecitabine + Valproic acid

Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin + Valproic acid

Bevacizumab + Capecitabine + Oxaliplatin + Valproic acid

Age Groups: senior | adult
Covered Countries ITA

Additional content available in CKB BOOST